Approach to patients with hepatitis C and persistently normal alanine aminotransferase levels

Y. H. Shaib, Kenneth J Vega, M. M. Jamal

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) infection is a common disease in the United States, with an overall prevalence of 1.8%. HCV accounts for ~20% of patients with acute hepatitis and 70% of those with chronic hepatitis. Chronic hepatitis C is a major cause of cirrhosis and hepatocellular carcinoma. In addition, HCV-related end-stage liver disease is the most common indication for liver transplantation. With this disease having such an impact on our healthcare system, treatment of chronic HCV and prevention of its complications assume utmost importance. Current therapy for hepatitis, although effective in some patients, remains problematic and is still evolving. Additionally, the decision to treat, although easy in some individuals, continues to be difficult and confusing in others. The decision is especially difficult in the group of patients with chronic HCV infection and persistently normal alanine aminotransferase (ALT) levels.

Original languageEnglish (US)
Pages (from-to)252-258
Number of pages7
JournalClinical Perspectives in Gastroenterology
Volume3
Issue number5
StatePublished - Oct 14 2000
Externally publishedYes

Fingerprint

Hepatitis C
Alanine Transaminase
Hepacivirus
Chronic Hepatitis C
Virus Diseases
Hepatitis
End Stage Liver Disease
Chronic Hepatitis
Liver Transplantation
Hepatocellular Carcinoma
Fibrosis
Delivery of Health Care
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Approach to patients with hepatitis C and persistently normal alanine aminotransferase levels. / Shaib, Y. H.; Vega, Kenneth J; Jamal, M. M.

In: Clinical Perspectives in Gastroenterology, Vol. 3, No. 5, 14.10.2000, p. 252-258.

Research output: Contribution to journalReview article

@article{6d7e9ddb434044488e77b26027b27c53,
title = "Approach to patients with hepatitis C and persistently normal alanine aminotransferase levels",
abstract = "Hepatitis C virus (HCV) infection is a common disease in the United States, with an overall prevalence of 1.8{\%}. HCV accounts for ~20{\%} of patients with acute hepatitis and 70{\%} of those with chronic hepatitis. Chronic hepatitis C is a major cause of cirrhosis and hepatocellular carcinoma. In addition, HCV-related end-stage liver disease is the most common indication for liver transplantation. With this disease having such an impact on our healthcare system, treatment of chronic HCV and prevention of its complications assume utmost importance. Current therapy for hepatitis, although effective in some patients, remains problematic and is still evolving. Additionally, the decision to treat, although easy in some individuals, continues to be difficult and confusing in others. The decision is especially difficult in the group of patients with chronic HCV infection and persistently normal alanine aminotransferase (ALT) levels.",
author = "Shaib, {Y. H.} and Vega, {Kenneth J} and Jamal, {M. M.}",
year = "2000",
month = "10",
day = "14",
language = "English (US)",
volume = "3",
pages = "252--258",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Approach to patients with hepatitis C and persistently normal alanine aminotransferase levels

AU - Shaib, Y. H.

AU - Vega, Kenneth J

AU - Jamal, M. M.

PY - 2000/10/14

Y1 - 2000/10/14

N2 - Hepatitis C virus (HCV) infection is a common disease in the United States, with an overall prevalence of 1.8%. HCV accounts for ~20% of patients with acute hepatitis and 70% of those with chronic hepatitis. Chronic hepatitis C is a major cause of cirrhosis and hepatocellular carcinoma. In addition, HCV-related end-stage liver disease is the most common indication for liver transplantation. With this disease having such an impact on our healthcare system, treatment of chronic HCV and prevention of its complications assume utmost importance. Current therapy for hepatitis, although effective in some patients, remains problematic and is still evolving. Additionally, the decision to treat, although easy in some individuals, continues to be difficult and confusing in others. The decision is especially difficult in the group of patients with chronic HCV infection and persistently normal alanine aminotransferase (ALT) levels.

AB - Hepatitis C virus (HCV) infection is a common disease in the United States, with an overall prevalence of 1.8%. HCV accounts for ~20% of patients with acute hepatitis and 70% of those with chronic hepatitis. Chronic hepatitis C is a major cause of cirrhosis and hepatocellular carcinoma. In addition, HCV-related end-stage liver disease is the most common indication for liver transplantation. With this disease having such an impact on our healthcare system, treatment of chronic HCV and prevention of its complications assume utmost importance. Current therapy for hepatitis, although effective in some patients, remains problematic and is still evolving. Additionally, the decision to treat, although easy in some individuals, continues to be difficult and confusing in others. The decision is especially difficult in the group of patients with chronic HCV infection and persistently normal alanine aminotransferase (ALT) levels.

UR - http://www.scopus.com/inward/record.url?scp=0033802062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033802062&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0033802062

VL - 3

SP - 252

EP - 258

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 5

ER -